Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility In Gosselies, Belgium
January 27, 2023
January 27, 2023
SOMERSET, New Jersey, Jan. 27 -- Catalent Inc., a pharma, biotech and consumer health company, issued the following news on Jan. 26, 2023:
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the opening of a new commercial-scale plasmid DNA (pDNA) manufacturing facility at its European center of excellence for cell therapies, in Gosselies, Belgium.
The state-of-the-art facility contains over 12,000 squ . . .
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the opening of a new commercial-scale plasmid DNA (pDNA) manufacturing facility at its European center of excellence for cell therapies, in Gosselies, Belgium.
The state-of-the-art facility contains over 12,000 squ . . .